Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils
Abstract Background Granulocyte–macrophage colony-stimulating factor (GM-CSF) has emerged as a crucial cytokine that activates myeloid cells to initiate tissue inflammation. However, the molecular actions of GM-CSF against innate immunity are still poorly characterized. Here, we investigated the in...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-018-1685-x |
id |
doaj-27edaba981094988a5ac773921c18ca5 |
---|---|
record_format |
Article |
spelling |
doaj-27edaba981094988a5ac773921c18ca52020-11-24T21:49:10ZengBMCArthritis Research & Therapy1478-63622018-08-012011910.1186/s13075-018-1685-xTofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophilsMakiko Yashiro Furuya0Tomoyuki Asano1Yuya Sumichika2Shuzo Sato3Hiroko Kobayashi4Hiroshi Watanabe5Eiji Suzuki6Hideko Kozuru7Hiroshi Yatsuhashi8Tomohiro Koga9Hiromasa Ohira10Hideharu Sekine11Atsushi Kawakami12Kiyoshi Migita13Department of Rheumatology, Fukushima Medical University School of MedicineDepartment of Rheumatology, Fukushima Medical University School of MedicineDepartment of Rheumatology, Fukushima Medical University School of MedicineDepartment of Rheumatology, Fukushima Medical University School of MedicineDepartment of Rheumatology, Fukushima Medical University School of MedicineDepartment of Rheumatology, Fukushima Medical University School of MedicineDepartment of Rheumatology, Ohta Nishinouchi General Hospital FoundationClinical Research Center, NHO Nagasaki Medical CenterClinical Research Center, NHO Nagasaki Medical CenterDepartment of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki UniversityDepartment of Gastroenterology, Fukushima Medical University School of MedicineDepartment of Immunology, Fukushima Medical University School of MedicineDepartment of Immunology and Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki UniversityDepartment of Rheumatology, Fukushima Medical University School of MedicineAbstract Background Granulocyte–macrophage colony-stimulating factor (GM-CSF) has emerged as a crucial cytokine that activates myeloid cells to initiate tissue inflammation. However, the molecular actions of GM-CSF against innate immunity are still poorly characterized. Here, we investigated the in vitro effects of GM-CSF on the activation of human myeloid lineages, neutrophils, and the underlying intracellular signaling mechanism, including inflammasome activation. Methods Human neutrophils were stimulated with GM-CSF in the presence or absence of tofacitinib. The cellular supernatants were analyzed for interleukin-1 beta (IL-1β) and caspase-1 by enzyme-linked immunosorbent assay (ELISA) methods. Pro-IL-1β mRNA expressions in human neutrophils were analyzed by real-time polymerase chain reaction. Protein phosphorylation of neutrophils was assessed by Western blot using phospho-specific antibodies. Results Stimulation with GM-CSF alone, but not tumor necrosis factor-alpha, was shown to increase the release of IL-1β and cleaved caspase-1 (p20) from human neutrophils. Tofacitinib, which inhibits GM-CSF–induced Janus kinase 2 (Jak2)-mediated signal transduction, completely abrogated GM-CSF–induced IL-1β and caspase-1 (p20) secretion from neutrophils. GM-CSF stimulation also induced pro-IL-1β mRNA expression in neutrophils and induced NLR family pyrin domain-containing 3 (NLRP3) protein expression. Although tofacitinib pretreatment marginally inhibited GM-CSF–induced pro-IL-1β mRNA expression, tofacitinib completely abrogated NLRP3 protein expression in neutrophils. Conclusions These results indicate that GM-CSF signaling induces NLRP3 expression and subsequent IL-1β production by affecting neutrophils, which may cause the activation of innate immunity. Therefore, GM-CSF is a key regulator of the NLRP3 inflammasome and IL-1β production by activating innate immune cells. This process can be blocked by tofacitinib, which interferes with JAK/STAT signaling pathways.http://link.springer.com/article/10.1186/s13075-018-1685-xGranulocyte–macrophage colony-stimulating factorInflammasomeInterleukin-1 betaJanus kinaseNeutrophilsNLR family pyrin domain-containing 3 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Makiko Yashiro Furuya Tomoyuki Asano Yuya Sumichika Shuzo Sato Hiroko Kobayashi Hiroshi Watanabe Eiji Suzuki Hideko Kozuru Hiroshi Yatsuhashi Tomohiro Koga Hiromasa Ohira Hideharu Sekine Atsushi Kawakami Kiyoshi Migita |
spellingShingle |
Makiko Yashiro Furuya Tomoyuki Asano Yuya Sumichika Shuzo Sato Hiroko Kobayashi Hiroshi Watanabe Eiji Suzuki Hideko Kozuru Hiroshi Yatsuhashi Tomohiro Koga Hiromasa Ohira Hideharu Sekine Atsushi Kawakami Kiyoshi Migita Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils Arthritis Research & Therapy Granulocyte–macrophage colony-stimulating factor Inflammasome Interleukin-1 beta Janus kinase Neutrophils NLR family pyrin domain-containing 3 |
author_facet |
Makiko Yashiro Furuya Tomoyuki Asano Yuya Sumichika Shuzo Sato Hiroko Kobayashi Hiroshi Watanabe Eiji Suzuki Hideko Kozuru Hiroshi Yatsuhashi Tomohiro Koga Hiromasa Ohira Hideharu Sekine Atsushi Kawakami Kiyoshi Migita |
author_sort |
Makiko Yashiro Furuya |
title |
Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils |
title_short |
Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils |
title_full |
Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils |
title_fullStr |
Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils |
title_full_unstemmed |
Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils |
title_sort |
tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced nlrp3 inflammasome activation in human neutrophils |
publisher |
BMC |
series |
Arthritis Research & Therapy |
issn |
1478-6362 |
publishDate |
2018-08-01 |
description |
Abstract Background Granulocyte–macrophage colony-stimulating factor (GM-CSF) has emerged as a crucial cytokine that activates myeloid cells to initiate tissue inflammation. However, the molecular actions of GM-CSF against innate immunity are still poorly characterized. Here, we investigated the in vitro effects of GM-CSF on the activation of human myeloid lineages, neutrophils, and the underlying intracellular signaling mechanism, including inflammasome activation. Methods Human neutrophils were stimulated with GM-CSF in the presence or absence of tofacitinib. The cellular supernatants were analyzed for interleukin-1 beta (IL-1β) and caspase-1 by enzyme-linked immunosorbent assay (ELISA) methods. Pro-IL-1β mRNA expressions in human neutrophils were analyzed by real-time polymerase chain reaction. Protein phosphorylation of neutrophils was assessed by Western blot using phospho-specific antibodies. Results Stimulation with GM-CSF alone, but not tumor necrosis factor-alpha, was shown to increase the release of IL-1β and cleaved caspase-1 (p20) from human neutrophils. Tofacitinib, which inhibits GM-CSF–induced Janus kinase 2 (Jak2)-mediated signal transduction, completely abrogated GM-CSF–induced IL-1β and caspase-1 (p20) secretion from neutrophils. GM-CSF stimulation also induced pro-IL-1β mRNA expression in neutrophils and induced NLR family pyrin domain-containing 3 (NLRP3) protein expression. Although tofacitinib pretreatment marginally inhibited GM-CSF–induced pro-IL-1β mRNA expression, tofacitinib completely abrogated NLRP3 protein expression in neutrophils. Conclusions These results indicate that GM-CSF signaling induces NLRP3 expression and subsequent IL-1β production by affecting neutrophils, which may cause the activation of innate immunity. Therefore, GM-CSF is a key regulator of the NLRP3 inflammasome and IL-1β production by activating innate immune cells. This process can be blocked by tofacitinib, which interferes with JAK/STAT signaling pathways. |
topic |
Granulocyte–macrophage colony-stimulating factor Inflammasome Interleukin-1 beta Janus kinase Neutrophils NLR family pyrin domain-containing 3 |
url |
http://link.springer.com/article/10.1186/s13075-018-1685-x |
work_keys_str_mv |
AT makikoyashirofuruya tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT tomoyukiasano tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT yuyasumichika tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT shuzosato tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT hirokokobayashi tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT hiroshiwatanabe tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT eijisuzuki tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT hidekokozuru tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT hiroshiyatsuhashi tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT tomohirokoga tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT hiromasaohira tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT hideharusekine tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT atsushikawakami tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils AT kiyoshimigita tofacitinibinhibitsgranulocytemacrophagecolonystimulatingfactorinducednlrp3inflammasomeactivationinhumanneutrophils |
_version_ |
1725889148953296896 |